Today in FirstWord: Merck & Co., suvorexant, Amgen, Xgeva, GlaxoSmithKline, OREXIGEN

Today in FirstWord: Merck &amp; Co., suvorexant, Amgen, Xgeva, GlaxoSmithKline, OREXIGEN

FirstWord Pharmaceutical News for Tuesday, February 7, 2012

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Tuesday, February 7, 2012

Sign up to save your podcasts

FirstWord Pharmaceutical News for Tuesday, February 7, 2012

FirstWord Pharmaceutical News for Tuesday, February 7, 2012